Gastric cancer (GC) is the 4th most common human malignant disease and the second-leading cancer-related deaths in the world(DeManzoni et al., 2016). Treatment with 5-fluorouracil/oxaliplatin (5-FU/oxaliplatin) chemotherapy has proven to significantly improve survivalof patients with metastatic GC
PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy
Sobhani, Navid;Generali, Daniele;Roviello, Giandomenico
2017-01-01
Abstract
Gastric cancer (GC) is the 4th most common human malignant disease and the second-leading cancer-related deaths in the world(DeManzoni et al., 2016). Treatment with 5-fluorouracil/oxaliplatin (5-FU/oxaliplatin) chemotherapy has proven to significantly improve survivalof patients with metastatic GCFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
PIIS2352396417302669.pdf
accesso aperto
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
141.42 kB
Formato
Adobe PDF
|
141.42 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
